A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC)
Background To figure out the efficacy, effects, safety and patient’s subjective perceptions of phacoemulsification with the active-fluidics system (AFS).Patients and methods This was a prospective, randomized, double-masked, controlled clinical study. Age-related cataract patients were recruited and...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2022-12-01
|
| Series: | Annals of Medicine |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2022.2098375 |
| _version_ | 1818517842627133440 |
|---|---|
| author | Yu Luo Hongyu Li Wenqian Chen Yi Gao Tianju Ma Zi Ye Zhaohui Li |
| author_facet | Yu Luo Hongyu Li Wenqian Chen Yi Gao Tianju Ma Zi Ye Zhaohui Li |
| author_sort | Yu Luo |
| collection | DOAJ |
| description | Background To figure out the efficacy, effects, safety and patient’s subjective perceptions of phacoemulsification with the active-fluidics system (AFS).Patients and methods This was a prospective, randomized, double-masked, controlled clinical study. Age-related cataract patients were recruited and randomly assigned to the AFS group and gravity-fluidics system (GFS) group in a ratio of 1:1 to have phacoemulsification. Participants were followed up at one day, one week, one month and three months postoperatively (Chinese Clinical Trial Registry, ChiCTR2100044409).Results The overall included participants were 107 finally. The total aspiration time of the AFS group was significantly less than that of the GFS group (p = .020), while no significant difference existed in cumulative dissipated energy and estimated fluid usage between the two groups. The best corrected visual acuity was significantly better in the AFS group at one day and one week postoperatively (p = .002, p = .038 respectively). The recovery of central corneal thickening and macular superficial vasculature increase was earlier in the AFS group. The central retinal thickness was significantly higher in the GFS group at one month and three months postoperatively (p = .029, p = .016 respectively). The incidence of corneal adverse events was higher in GFS group (p = .035). No serious adverse events occurred in either group. Pain scores and the scores of Cat-PROM5 questionnaire of the AFS group were significantly lower than that of the GFS group (p = .011, p = .002 respectively).Conclusion AFS improves the efficiency, effects, safety and patients’ subjective perceptions of phacoemulsification compared with GFS. It is worthwhile to promote its application in cataract surgery.KEY MESSAGESThe active-fluidics system automatically detects and maintains stable intraocular pressure at the set value.The active-fluidics system improves the efficiency, effects, safety and patients’ subjective perceptions in phacoemulsification. |
| first_indexed | 2024-12-11T01:01:45Z |
| format | Article |
| id | doaj.art-42f72444112a4275b116b869aeb3be8a |
| institution | Directory Open Access Journal |
| issn | 0785-3890 1365-2060 |
| language | English |
| last_indexed | 2024-12-11T01:01:45Z |
| publishDate | 2022-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Annals of Medicine |
| spelling | doaj.art-42f72444112a4275b116b869aeb3be8a2022-12-22T01:26:19ZengTaylor & Francis GroupAnnals of Medicine0785-38901365-20602022-12-015411977198710.1080/07853890.2022.2098375A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC)Yu Luo0Hongyu Li1Wenqian Chen2Yi Gao3Tianju Ma4Zi Ye5Zhaohui Li6Medical School of Chinese People’s Liberation Army, Beijing, ChinaMedical School of Chinese People’s Liberation Army, Beijing, ChinaDepartment of Ophthalmology, Chinese People’s Liberation Army General Hospital, Beijing, ChinaDepartment of Ophthalmology, Chinese People’s Liberation Army General Hospital, Beijing, ChinaDepartment of Ophthalmology, Chinese People’s Liberation Army General Hospital, Beijing, ChinaDepartment of Ophthalmology, Chinese People’s Liberation Army General Hospital, Beijing, ChinaMedical School of Chinese People’s Liberation Army, Beijing, ChinaBackground To figure out the efficacy, effects, safety and patient’s subjective perceptions of phacoemulsification with the active-fluidics system (AFS).Patients and methods This was a prospective, randomized, double-masked, controlled clinical study. Age-related cataract patients were recruited and randomly assigned to the AFS group and gravity-fluidics system (GFS) group in a ratio of 1:1 to have phacoemulsification. Participants were followed up at one day, one week, one month and three months postoperatively (Chinese Clinical Trial Registry, ChiCTR2100044409).Results The overall included participants were 107 finally. The total aspiration time of the AFS group was significantly less than that of the GFS group (p = .020), while no significant difference existed in cumulative dissipated energy and estimated fluid usage between the two groups. The best corrected visual acuity was significantly better in the AFS group at one day and one week postoperatively (p = .002, p = .038 respectively). The recovery of central corneal thickening and macular superficial vasculature increase was earlier in the AFS group. The central retinal thickness was significantly higher in the GFS group at one month and three months postoperatively (p = .029, p = .016 respectively). The incidence of corneal adverse events was higher in GFS group (p = .035). No serious adverse events occurred in either group. Pain scores and the scores of Cat-PROM5 questionnaire of the AFS group were significantly lower than that of the GFS group (p = .011, p = .002 respectively).Conclusion AFS improves the efficiency, effects, safety and patients’ subjective perceptions of phacoemulsification compared with GFS. It is worthwhile to promote its application in cataract surgery.KEY MESSAGESThe active-fluidics system automatically detects and maintains stable intraocular pressure at the set value.The active-fluidics system improves the efficiency, effects, safety and patients’ subjective perceptions in phacoemulsification.https://www.tandfonline.com/doi/10.1080/07853890.2022.2098375Cataractphacoemulsificationactive-fluidics systemgravity-fluidics systemrandomized controlled trial |
| spellingShingle | Yu Luo Hongyu Li Wenqian Chen Yi Gao Tianju Ma Zi Ye Zhaohui Li A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) Annals of Medicine Cataract phacoemulsification active-fluidics system gravity-fluidics system randomized controlled trial |
| title | A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) |
| title_full | A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) |
| title_fullStr | A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) |
| title_full_unstemmed | A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) |
| title_short | A prospective randomized clinical trial of active-fluidics versus gravity-fluidics system in phacoemulsification for age-related cataract (AGSPC) |
| title_sort | prospective randomized clinical trial of active fluidics versus gravity fluidics system in phacoemulsification for age related cataract agspc |
| topic | Cataract phacoemulsification active-fluidics system gravity-fluidics system randomized controlled trial |
| url | https://www.tandfonline.com/doi/10.1080/07853890.2022.2098375 |
| work_keys_str_mv | AT yuluo aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT hongyuli aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT wenqianchen aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT yigao aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT tianjuma aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT ziye aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT zhaohuili aprospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT yuluo prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT hongyuli prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT wenqianchen prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT yigao prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT tianjuma prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT ziye prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc AT zhaohuili prospectiverandomizedclinicaltrialofactivefluidicsversusgravityfluidicssysteminphacoemulsificationforagerelatedcataractagspc |